Capula Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Capula Management's GILD Position: Q4 2025 in Review
Capula Management sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 6,009 shares — an estimated $730K sold.
Capula Management first reported a position in GILD in Q3 2019 and held it in 16 quarters. The position peaked at $7.97M in Q3 2020. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.
- Capula Management reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
- Capula Management sold 6,009 Gilead Sciences shares in Q4 2025, an estimated $730K.
- Capula Management first reported a position in Gilead Sciences in Q3 2019 and held it in 16 quarters.
- Capula Management's Gilead Sciences position peaked at $7.97M in Q3 2020.
- 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.
Based on Capula Management's 13F filing for Q4 2025, filed 13 Feb 2026.